Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 12/20 | 0.47 |
| ▸ | BTK | Q06187 | 2/20 | 0.47 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.42 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.41 |
| ▸ | PLK4 | O00444 | 2/20 | 0.40 |
| ▸ | AR | P10275 | 3/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 6/20 | 0.40 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.39 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31595777 | 0.87 | CRBN (0.53) | CRBNBTKPTK2ALKPLK4 | |
| SCHEMBL31595385 | 0.83 | CRBN (0.46) | CRBNBTKPTK2DDB1 | |
| SCHEMBL23267690 | 0.83 | CRBN (0.46) | CRBNBTKPTK2DDB1 | |
| SCHEMBL23267722 | 0.79 | CRBN (0.53) | CRBNBTKPTK2ALKAR | |
| SCHEMBL31595461 | 0.79 | CRBN (0.53) | CRBNBTKPTK2ALKAR | |
| SCHEMBL31595323 | 0.78 | CRBN (0.51) | CRBNBTKPTK2ALKPLK4 | |
| SCHEMBL23267708 | 0.78 | CRBN (0.48) | CRBNBTKPTK2ALKPLK4 | |
| SCHEMBL31595625 | 0.78 | CRBN (0.48) | CRBNBTKPTK2ALKPLK4 | |
| SCHEMBL31595686 | 0.76 | PTK2 (0.51) | CRBNBTKPTK2ALKAR | |
| SCHEMBL23267313 | 0.76 | CRBN (0.49) | CRBNBTKPTK2ALKPLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096710-A1 | MODULATORS OF BCL6 AS LIGAND DIRECTED DEGRADERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-05-08 | — | — | WO | disclosed |